| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1174 | 2019 |
| Infections Caused by Scedosporium spp KJ Cortez, E Roilides, F Quiroz-Telles, J Meletiadis, C Antachopoulos, ... Clinical microbiology reviews 21 (1), 157-197, 2008 | 733 | 2008 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 695 | 2014 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 437 | 2014 |
| Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ... Emerging infectious diseases 21 (6), 1041, 2015 | 358 | 2015 |
| In vitro susceptibilities of zygomycetes to conventional and new antifungals E Dannaoui, J Meletiadis, JW Mouton, JFGM Meis, PE Verweij Journal of Antimicrobial Chemotherapy 51 (1), 45-52, 2003 | 347 | 2003 |
| Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in … J Meletiadis, S Pournaras, E Roilides, TJ Walsh Antimicrobial agents and chemotherapy 54 (2), 602-609, 2010 | 341 | 2010 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, G De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 294 | 2014 |
| Comparison of NCCLS and 3-(4, 5-dimethyl-2-thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development … J Meletiadis, JFGM Meis, JW Mouton, JP Donnelly, PE Verweij Journal of Clinical Microbiology 38 (8), 2949-2954, 2000 | 284 | 2000 |
| In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates J Meletiadis, JW Mouton, JFGM Meis, PE Verweij Antimicrobial Agents and Chemotherapy 47 (1), 106-117, 2003 | 282 | 2003 |
| Analysis of growth characteristics of filamentous fungi in different nutrient media J Meletiadis, JFGM Meis, JW Mouton, PE Verweij Journal of Clinical microbiology 39 (2), 478-484, 2001 | 267 | 2001 |
| In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates J Meletiadis, JFGM Meis, JW Mouton, JL Rodriquez-Tudela, JP Donnelly, ... Antimicrobial Agents and Chemotherapy 46 (1), 62-68, 2002 | 261 | 2002 |
| Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values MC Arendrup, A Prakash, J Meletiadis, C Sharma, A Chowdhary Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00485-17, 2017 | 235 | 2017 |
| Colorimetric Assay for Antifungal Susceptibility Testing ofAspergillus Species J Meletiadis, JW Mouton, JFGM Meis, BA Bouman, JP Donnelly, ... Journal of clinical microbiology 39 (9), 3402-3408, 2001 | 191 | 2001 |
| EUCAST definitive document EDef 9.3. Method for the determination of broth microdilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds SJH M. C. Arendrup , J Guinea , M. Cuenca-Estrella , J. Meletiadis, J. W ... | 182* | 2017 |
| EUCAST definitive document E. DEF 7.3 MC Arendrup, J Guinea, M Cuenca-Estrella, J Meletiadis, JW Mouton, ... Method for the determination of broth dilution minimum inhibitory …, 2015 | 169* | 2015 |
| Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis T Stergiopoulou, J Meletiadis, E Roilides, DE Kleiner, R Schaufele, ... American journal of clinical pathology 127 (3), 349-355, 2007 | 159 | 2007 |
| In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans J Meletiadis, JW Mouton, JL Rodriguez-Tudela, JFGM Meis, PE Verweij Antimicrobial agents and chemotherapy 44 (2), 470-472, 2000 | 126 | 2000 |
| In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms A Katragkou, M McCarthy, EL Alexander, C Antachopoulos, J Meletiadis, ... Journal of Antimicrobial Chemotherapy 70 (2), 470-478, 2015 | 124 | 2015 |
| Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models J Meletiadis, PE Verweij, DTA Te Dorsthorst, JFGM Meis, JW Mouton Medical mycology 43 (2), 133-152, 2005 | 120 | 2005 |
